Journal article
Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial
Abstract
BACKGROUND: Tranexamic acid reduces surgical bleeding and reduces death due to bleeding in patients with trauma. Meta-analyses of small trials show that tranexamic acid might decrease deaths from gastrointestinal bleeding. We aimed to assess the effects of tranexamic acid in patients with gastrointestinal bleeding.
METHODS: We did an international, multicentre, randomised, placebo-controlled trial in 164 hospitals in 15 countries. Patients were …
Authors
Roberts I; Shakur-Still H; Afolabi A; Akere A; Arribas M; Brenner A; Chaudhri R; Gilmore I; Halligan K; Hussain I
Journal
The Lancet, Vol. 395, No. 10241, pp. 1927–1936
Publisher
Elsevier
Publication Date
6 2020
DOI
10.1016/s0140-6736(20)30848-5
ISSN
0140-6736
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Acute DiseaseAdultAgedAntifibrinolytic AgentsCase-Control StudiesDouble-Blind MethodFemaleGastrointestinal HemorrhageHumansInjections, IntravenousMaleMiddle AgedMyocardial InfarctionOdds RatioOutcome Assessment, Health CarePlacebosPredictive Value of TestsPulmonary EmbolismStrokeThromboembolismTranexamic AcidVenous Thrombosis